We are live on ! Find out more
CLB icon

Core Laboratories

178 hedge funds and large institutions have $1.16B invested in Core Laboratories in 2023 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 56 increasing their positions, 66 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

296% more call options, than puts

Call options by funds: $1.01M | Put options by funds: $255K

175% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 8

9% more funds holding

Funds holding: 164178 (+14)

2% more capital invested

Capital invested by funds: $1.13B → $1.16B (+$26.3M)

0.88% less ownership

Funds ownership: 104.51%103.64% (-0.88%)

15% less repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 66

Holders
178
Holders Change
+14
Holders Change %
+8.54%
% of All Funds
2.82%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
22
Increased
56
Reduced
66
Closed
8
Calls
$1.01M
Puts
$255K
Net Calls
+$755K
Net Calls Change
-$568K

CLB Hedge Fund Activity: Q3 2023 in Review

178 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q3 2023, worth a combined $1.16B — up 2.3% from $1.13B a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new CLB positions and 8 closed out — a net gain of 14 holders — while 56 added to existing stakes and 66 trimmed.

The largest buyer was LMR Partners, opening a new position worth an estimated $10.7M. The largest seller was Fred Alger Management, cutting an estimated $34.4M.

  • 178 institutional investors held Core Laboratories (CLB) as of Q3 2023, up from 164 in Q2 2023.
  • Funds reported $1.16B of Core Laboratories stock for Q3 2023, up 2.3% quarter-over-quarter.
  • 22 funds opened new Core Laboratories positions in Q3 2023 and 8 closed out, a net change of +14 holders.
  • The largest Core Laboratories buyer in Q3 2023 was LMR Partners, an estimated $10.7M added.
  • The largest Core Laboratories seller in Q3 2023 was Fred Alger Management, an estimated $34.4M sold.

Based on aggregated 13F filings for Q3 2023.